Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute

  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK


Video Library


Babraham Bioscience Technologies Announces that Cancer Research Technology (CRT) is to lease new chemistry facilities at the Babraham Research Campus

26th November 2012


Babraham Bioscience technologies today announced that Cancer Research Technology Limited (CRT), the cancer-focused technology development and commercialisation arm of Cancer Research UK – the world’s largest cancer charity, has taken a lease in the new chemistry building currently under construction at the Babraham Research Campus.  The building is due for completion in April 2013 and will house part of CRT’s Discovery Laboratories, its early-stage drug discovery operation.


The Babraham Research Campus has established itself as a hub of bioscience innovation at the heart of the Cambridge cluster and is already home to 36 innovative biomedical companies. This new research facility has been funded through the £44M capital development project awarded to the Biotechnology and Biological Sciences Research Council (BBSRC), which was announced by the Chancellor in 2011.


The building offers around 16,000 sq ft of lettable space, which will include 24 fume hoods, open plan bench space, offices and meeting rooms. CRT has taken a lease on half of the building, which will accommodate up to 30 of their researchers working in the area of cancer therapeutics (both bioscience and chemistry).


This is the second building financed through this capital project funding, the first being Babraham’s most recent Bioincubator Building, Moneta, which opened in April 2012. To date there are five Bioincubator Buildings at the campus, underscoring Babraham’s continuing commitment to nurturing early-stage enterprises and supporting biomedical innovation in the region. The Babraham Research Campus is strategically supported by the BBSRC.


Contact details:
Dr Claire Cockcroft   
Head, External Relations
The Babraham Institute
Tel:       +44 (0)1223 496260
Fax:      +44 (0)1223 496002
Mobile:  +44 (0)7786 335978


Derek Jones, Chief Executive
Babraham Bioscience Technologies Limited
Tel:       +44 (0)1223 496262

Babraham Research Campus
CB22 3AT
United Kingdom and


Babraham Bioscience Technologies Ltd.

Babraham Bioscience Technologies Ltd Babraham Bioscience Technologies Ltd (BBT) is responsible for the commercial development of the Babraham Research Campus.  The Babraham Research Campus is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation.  The Campus provides companies laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster. Website:


The Babraham Institute

The Babraham Institute, which receives strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), undertakes international quality life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. The institute received £22.4M investment from BBSRC in 2010-11. The Institute’s research provides greater understanding of the biological events that underlie the normal functions of cells and the implication of failure or abnormalities in these processes. Research focuses on signalling and genome regulation, particularly the interplay between the two and how epigenetic signals can influence important physiological adaptations during the lifespan of an organism. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and healthier ageing. (



The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, and with an annual budget of around £445M, we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

For more information about BBSRC, our science and our impact see:

For more information about BBSRC strategically funded institutes see:


Cancer Research Technology (CRT) is a specialist commercialization and development company, which aims to develop new discoveries in cancer research for the benefit of cancer patients. CRT works closely with leading international cancer scientists and their institutes to protect intellectual property arising from their research and to establish links with commercial partners. CRT facilitates the discovery, development and marketing of new cancer therapeutics, vaccines, diagnostics and enabling technologies. CRT is a wholly owned subsidiary of Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research. Further information about CRT can be found at



Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom